Kidney Stone Management Devices Market Size, Share, Growth and Forecast (2026 - 2036)

Kidney Stone Management Devices Market Analysis and Forecast by Fact.MR

The global kidney stone management devices market covers medical devices used for the detection, fragmentation, and removal of renal and ureteral calculi. Device categories include lithotripters, ureteroscopes, percutaneous nephroscopy instruments, and stone retrieval accessories. These products serve hospitals, ambulatory surgical centers, and urology clinics. Growth is shaped by rising kidney stone prevalence, expanding adoption of minimally invasive treatment approaches, and increasing demand for laser-based lithotripsy systems that offer improved stone fragmentation with reduced tissue damage.

Summary of Kidney Stone Management Devices Market

• Market Snapshot
  • In 2025, the global Kidney Stone Management Devices Market was valued at approximately USD 2.1 billion.
  • The market is estimated to reach USD 2.21 billion in 2026 and is projected to attain USD 3.67 billion by 2036.
  • The kidney stone management devices market is likely to expand at a CAGR of 5.2% during the forecast period.
  • The market is anticipated to create an absolute dollar opportunity of USD 1.46 billion between 2026 and 2036.
  • Lithotripters accounts for 46% of device share in 2026.
  • USA (5.9%) and Mexico (5.6%) are the key growth markets during the forecast period.
• Demand and Growth Drivers
  • Rising global prevalence of kidney stones, driven by dietary changes, obesity, and dehydration patterns, is expanding the addressable patient population.
  • Growing adoption of minimally invasive treatments including extracorporeal shockwave lithotripsy and laser ureteroscopy is increasing device utilization rates.
  • Expansion of urology department capacity across hospitals in developing economies is creating new procurement demand for lithotripsy and endoscopy equipment.
  • Technological advances in laser lithotripsy systems offering improved stone fragmentation with reduced tissue damage are driving equipment upgrades.
  • Increasing outpatient and ambulatory surgical center procedures for kidney stone management are supporting demand for portable and compact device formats.
  • Product and Segment View
  • Lithotripters accounts for 46% of the device segment in 2026, supported by broad applicability across primary end-use categories.
  • Hospitals represents 61% of the setting segment in 2026, reflecting sustained institutional demand.
  • Key segmentation includes: Device: Lithotripters, Ureteroscopes, Others. Setting: Hospitals, Specialty Clinics, Others. Approach: Non Invasive, Minimally Invasive, Others. End Use: Hospitals, Specialty Clinics, Ambulatory Surgical Centers, Diagnostic Centers.
• Geography and Competitive Outlook
  • North America maintains a leading position supported by established healthcare infrastructure and strong institutional procurement.
  • Europe shows steady demand driven by regulatory frameworks, clinical standards, and aging demographics.
  • Asia Pacific is the fastest-growing region, led by USA (5.9%) and Mexico (5.6%).
  • Key players include Boston Scientific Corporation, Olympus Corporation, Karl Storz SE & Co. KG, Cook Medical Inc., Richard Wolf GmbH, Dornier MedTech GmbH.
• Analyst Opinion
  • Shambhu Nath Jha, Principal Consultant at Fact.MR, says 'The kidney stone device market is being driven by the convergence of rising stone prevalence and the shift toward minimally invasive treatment. Laser lithotripsy is replacing older shockwave systems in many hospitals, and single-use ureteroscopes are gaining share by eliminating reprocessing costs. The commercial opportunity is in bundled procedure kits that combine access devices, lithotripsy fibers, and retrieval tools in a single procurement package, simplifying hospital supply chain management.'

Key Growth Drivers, Constraints, and Opportunities

Key Factors Driving Growth

• Rising disease prevalence and aging populations are expanding the addressable patient population requiring specialized products.
• Increasing institutional adoption and clinical guideline integration are supporting procurement growth in hospital and long-term care settings.
• Expanding healthcare infrastructure in developing economies is creating new procurement demand across emerging market facilities.

Key Market Constraints

• Cost sensitivity in price-constrained healthcare settings limits adoption of premium products.
• Limited clinical awareness in certain markets restricts demand growth for specialized products.
• Regulatory differences across countries create compliance complexity for manufacturers.

Key Opportunity Areas

• Development of integrated care kits combining multiple product categories creates higher-value procurement opportunities.
• Expansion of homecare programs opens new demand channels beyond traditional institutional settings.
• Product innovation in safety, monitoring, and ease-of-use features supports premiumization.

Segment-wise Analysis of the Kidney Stone Management Devices Market

• Lithotripters holds 46% of the device segment in 2026.
• Hospitals represents 61% of the setting segment in 2026.
• The kidney stone management devices market is segmented by device, setting, approach, end use, and region.

Which Device Segment Dominates the Kidney Stone Management Devices Market?

Lithotripters is expected to account for approximately 46% of the device segment in 2026. This leadership reflects sustained demand from primary use cases, established procurement patterns, and broad applicability across key end-use categories.

Other segments within this category serve specialized requirements and contribute to overall market diversification. Competition across segments is shaped by product performance, pricing, and alignment with institutional procurement standards.

Which Setting Segment Dominates the Kidney Stone Management Devices Market?

Hospitals is expected to account for approximately 61% of the setting segment in 2026. Demand is shaped by institutional procurement requirements, clinical adoption patterns, and established end-use applications.

Remaining segments serve specific clinical, demographic, or application needs, each contributing to the overall market through differentiated demand drivers and procurement channels.

Which Product Trend is Shaping the Next Phase of Growth in the Kidney Stone Management Devices Market?

Single-use digital ureteroscopes with integrated laser lithotripsy are emerging as the fastest-growing product category. Their adoption is projected to rise as hospitals shift from reusable scopes requiring reprocessing toward disposable devices that eliminate cross-contamination risk, reduce turnaround time, and simplify inventory management. This is particularly relevant in ambulatory surgical settings where procedure throughput and infection control are operational priorities.

The shift toward single-use ureteroscopes reflects a broader change in hospital procurement priorities. Facilities are moving from capital equipment purchases with ongoing reprocessing costs toward per-procedure consumable models that simplify budgeting and reduce sterilization infrastructure requirements. As a result, disposable scopes are gaining share against reusable systems, especially in markets where infection control regulations are tightening.

Regional Outlook Across Key Markets

• USA leads growth at 5.9%, supported by expanding healthcare infrastructure and rising demand for specialized products.
• Mexico follows at 5.6%, driven by government healthcare programs and increasing clinical adoption.
• Mature markets show steady growth supported by established healthcare systems and replacement demand.

CAGR Table

Source: Fact MR (FMR) analysis, based on proprietary forecasting model and primary research.

Market Outlook for Kidney Stone Management Devices in USA

The USA kidney stone management devices market is projected to grow at a CAGR of 5.9% through 2036. Demand is supported by expanding healthcare infrastructure and rising institutional investment.

• Healthcare infrastructure expansion supports procurement growth.
• Clinical adoption rates continue to improve across key facilities.
• Government programs and regulatory frameworks support market development.

Demand Trends in Kidney Stone Management Devices in Mexico

The Mexico kidney stone management devices market is projected to grow at a CAGR of 5.6% through 2036. Demand is supported by expanding healthcare infrastructure and rising institutional investment.

• Healthcare infrastructure expansion supports procurement growth.
• Clinical adoption rates continue to improve across key facilities.
• Government programs and regulatory frameworks support market development.

Growth Assessment for Kidney Stone Management Devices in Germany

The Germany kidney stone management devices market is projected to grow at a CAGR of 5.2% through 2036. Demand is supported by expanding healthcare infrastructure and rising institutional investment.

• Healthcare infrastructure expansion supports procurement growth.
• Clinical adoption rates continue to improve across key facilities.
• Government programs and regulatory frameworks support market development.

Market Analysis of Kidney Stone Management Devices in France

The France kidney stone management devices market is projected to grow at a CAGR of 5.1% through 2036. Demand is supported by expanding healthcare infrastructure and rising institutional investment.

• Healthcare infrastructure expansion supports procurement growth.
• Clinical adoption rates continue to improve across key facilities.
• Government programs and regulatory frameworks support market development.

Opportunity Outlook for Kidney Stone Management Devices in UK

The UK kidney stone management devices market is projected to grow at a CAGR of 4.9% through 2036. Demand is supported by expanding healthcare infrastructure and rising institutional investment.

• Healthcare infrastructure expansion supports procurement growth.
• Clinical adoption rates continue to improve across key facilities.
• Government programs and regulatory frameworks support market development.

Competitive Benchmarking and Company Positioning

Kidney Stone Management Devices Market Analysis By Company

• Boston Scientific Corporation, Olympus Corporation, Karl Storz SE & Co. KG hold strong positions through broad portfolios and established distribution networks.
• Cook Medical Inc., Richard Wolf GmbH, Dornier MedTech GmbH compete across specific segments, price tiers, and regional markets.
• Competition is shaped by product quality, clinical evidence, pricing, and distribution capabilities.

The competitive landscape is moderately fragmented, with established medical companies competing alongside specialized manufacturers. Product quality, clinical evidence, and service support drive purchasing decisions.

Strategic priorities include expanding product portfolios, strengthening distribution networks, and developing service-linked revenue models.

Key Companies in the Kidney Stone Management Devices Market

Boston Scientific Corporation, Olympus Corporation, Karl Storz SE & Co. KG, Cook Medical Inc. are among the leading players. Richard Wolf GmbH, Dornier MedTech GmbH, Coloplast A/S, EDAP TMS SA hold established positions. Stryker Corporation, Medtronic plc compete through focused product offerings.

Recent Industry Developments

• Boston Scientific Corporation - Product Portfolio Expansion (January 2026)
• Boston Scientific Corporation expanded its product portfolio targeting growing demand segments.
• Olympus Corporation - Market Expansion (2025)
• Olympus Corporation broadened geographic presence through distribution partnerships.
• Karl Storz SE & Co. KG - Technology Enhancement (2025)
• Karl Storz SE & Co. KG introduced technology improvements targeting performance and compliance.

Leading Companies Shaping the Kidney Stone Management Devices Market

• Boston Scientific Corporation
• Olympus Corporation
• Karl Storz SE & Co. KG
• Cook Medical Inc.
• Richard Wolf GmbH
• Dornier MedTech GmbH
• Coloplast A/S
• EDAP TMS SA
• Stryker Corporation
• Medtronic plc

Sources and Research References

• Boston Scientific Corporation. Product portfolio and corporate updates.
• Olympus Corporation. Product launches and market announcements.
• World Health Organization. Disease prevalence and healthcare infrastructure data.
• Primary interviews with manufacturers, distributors, clinicians, and end users.

This bibliography is provided for reader reference and is not exhaustive. The full report contains the complete reference list and detailed citations.

Key Questions This Report Addresses

• What is the current and future size of the Kidney Stone Management Devices Market?
• How fast is the market expected to grow between 2026 and 2036?
• Which device is likely to lead the market by 2026?
• Which setting segment accounts for the highest demand?
• What factors are driving demand globally?
• Which countries show the fastest growth through 2036?
• Who are the key companies in the Kidney Stone Management Devices Market?
• How does Fact.MR estimate and validate the forecast?
• What are the key constraints and opportunities?
• How is product innovation influencing growth?

Kidney Stone Management Devices Market Definition

The kidney stone management devices market covers medical devices for detection, fragmentation, and removal of renal and ureteral calculi. It includes lithotripters, ureteroscopes, nephroscopy instruments, and retrieval accessories.

MarketKidney Stone Management Devices Market

• The scope covers global and regional market size and forecasts for 2026 to 2036 across key segmentation categories and regions.
• It includes regional demand analysis based on disease prevalence, healthcare spending, institutional procurement patterns, and regulatory frameworks.
• The report covers pricing analysis, competitive landscape, and distribution strategies of leading companies.
• It includes technology trends, product innovation, and emerging market dynamics influencing demand growth.

Kidney Stone Management Devices Market Exclusions

• The scope excludes products and services outside the defined market boundary serving different clinical or commercial purposes.
• It excludes non-commercial, custom-built, or research-only systems not available through standard procurement.
• The report excludes informal products with limited quality standardization and market visibility.
• It also excludes adjacent categories that differ in product classification and regulatory pathway.

Kidney Stone Management Devices Market Research Methodology

• The methodology combines secondary research, primary interviews, and forecast modelling.
• It draws on 120+ secondary sources and benchmarks 65+ company product portfolios.
• Market sizing covers 30+ countries through a demand-side model, supported by top-down validation.
• The model cross-checks demand with shipments, pricing trends, channel mix, and product launches.
• Primary validation includes 25+ interviews across manufacturers, distributors, and end users.
• Final estimates go through trade-flow checks, sales-pattern review, and sensitivity testing.